thiazolyl blue has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joshi, SS; Pavletic, ZS; Wang, P | 1 |
Alaoui-Jamali, M; Aubin, R; Batist, G; Bramson, J; Christodoulopoulos, G; McQuillan, A; Panasci, LC | 1 |
Brugiatelli, M; Callea, I; Callea, V; Console, G; Morabito, F; Stelitano, C | 1 |
Lambert, E; Rees, JK; Twentyman, PR | 1 |
4 other study(ies) available for thiazolyl blue and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Topics: Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Caenorhabditis elegans Proteins; Cell Cycle; Cell Division; Cell Line, Tumor; Coloring Agents; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Fluorescein-5-isothiocyanate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Oligonucleotides, Antisense; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Vidarabine | 2002 |
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
Topics: B-Lymphocytes; Chlorambucil; Cisplatin; Cross-Linking Reagents; DNA Adducts; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Resistance; Humans; Inactivation, Metabolic; Leukemia, Lymphocytic, Chronic, B-Cell; Melphalan; Methyl Methanesulfonate; Mitomycin; Nitrogen Mustard Compounds; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1995 |
In vitro drug-induced cytotoxicity predicts clinical response to high-dose chlorambucil in B-cell chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Agents, Alkylating; Cell Survival; Chlorambucil; Coloring Agents; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Multivariate Analysis; Neoplastic Stem Cells; Remission Induction; Tetrazolium Salts; Thiazoles; Treatment Outcome | 1999 |
Resistance circumvention strategies tested in clinical leukaemia specimens using the MTT colorimetric assay.
Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine | 1992 |